Literature DB >> 13955205

The effect of 6-mercaptopurine on delayed hypersensitivity in guinea pigs.

J R HOYER, L W HOYER, R A GOOD, R M CONDIE.   

Abstract

The development of tuberculin hypersensitivity in guinea pigs after BCG stimulation was suppressed by intramuscular administration of 50 mg/kg/day of 6-mercaptopurine started at the time of stimulation. Fasting of guinea pigs after BCG stimulation had no effect on the development of tuberculin hypersensitivity.

Entities:  

Keywords:  ANTIGEN-ANTIBODY REACTIONS; MERCAPTOPURINE

Mesh：

Substances：

Year:  1962        PMID： 13955205      PMCID： PMC2137566          DOI： 10.1084/jem.116.5.679

Source DB:  PubMed          Journal:  J Exp Med        ISSN： 0022-1007            Impact factor:   14.307


  9 in total

1.  The effect of 6-mercaptopurine on primary and secondary immune responses.

Authors:  R SCHWARTZ; A EISNER; W DAMESHEK
Journal:  J Clin Invest       Date:  1959-08       Impact factor: 14.808

2.  Antibody production in guinea pigs receiving 6-mercaptopurine.

Authors:  D S GENGHOF; J R BATTISTO
Journal:  Proc Soc Exp Biol Med       Date:  1961 Aug-Sep

3.  The effects of aminopterin on guinea pig tuberculosis.

Authors:  R W PRICHARD; D M HAYES
Journal:  Am J Pathol       Date:  1961-03       Impact factor: 4.307

4.  Prevention of secondary immune response with 6-mercaptopurine.

Authors:  E S LAPLANTE; R M CONDIE; R A GOOD
Journal:  J Lab Clin Med       Date:  1962-04

5.  Experimental allergic encephalomyelitis: the effect of 6-mercaptopurine.

Authors:  L W HOYER; R A GOOD; R M CONDIE
Journal:  J Exp Med       Date:  1962-09-01       Impact factor: 14.307

6.  Passive transfer of tuberculin sensitivity by tritiated thymidine-labeled lymphoid cells.

Authors:  J S NAJARIAN; J D FELDMAN
Journal:  J Exp Med       Date:  1961-11-01       Impact factor: 14.307

7.  The effect of aminomethylpteroylglutamic acid on the development of skin hypersensitivity and on antibody formation in guinea pigs.

Authors:  R M FRIEDMAN; C E BUCKLER; S BARON
Journal:  J Exp Med       Date:  1961-08-01       Impact factor: 14.307

8.  The specificity of allergic reactions. I. Delayed versus Arthus hypersensitivity.

Authors:  S B SALVIN; R F SMITH
Journal:  J Exp Med       Date:  1960-04-01       Impact factor: 14.307

9.  The use of specific "lymphocyte" antisera to inhibit hypersensitive reactions of the "delayed" type.

Authors:  B H WAKSMAN; S ARBOUYS; B G ARNASON
Journal:  J Exp Med       Date:  1961-12-01       Impact factor: 14.307
  9 in total
  8 in total

1.  Substituted 9-benzyladenines: inhibitors of inflammation associated with the delayed hypersensitivity skin reaction.

Authors:  R J Wojnar; R J Brittain
Journal:  Agents Actions       Date:  1975-05

Review 2.  ASPERGILLOSIS; REPORT OF TWO INSTANCES IN CHILDREN ASSOCIATED WITH ACUTE LEUKEMIA AND REVIEW OF THE PERTINENT LITERATURE.

Authors:  J W LANDAU; V D NEWCOMER; J SCHULZ
Journal:  Mycopathol Mycol Appl       Date:  1963-10-30

3.  INHIBITION BY 6-MERCAPTOPURINE OF POLYARTHRITIS INDUCED BY FREUND'S ADJUVANT.

Authors:  J L KALLIOMAEKI; H A SAARIMAA; P TOIVANEN
Journal:  Ann Rheum Dis       Date:  1964-01       Impact factor: 19.103

4.  STUDIES ON THE SUPPRESSION OF IMMUNE RESPONSES BY THE PERIWINKLE ALKALOIDS VINCRISTINE AND VINBLASTINE.

Authors:  A C AISENBERG; B WILES
Journal:  J Clin Invest       Date:  1964-12       Impact factor: 14.808

5.  THE EFFECT OF GRANULOCYTOPENIA ON EXPERIMENTAL TUBERCULIN FEVER.

Authors:  I V ALLEN
Journal:  Immunology       Date:  1965-04       Impact factor: 7.397

6.  Survival of candida septicaemia treated with amphotericin B.

Authors:  A B Mitchell; G Hosking; I T Magrath; C P Farthing
Journal:  Postgrad Med J       Date:  1972-07       Impact factor: 2.401

7.  Structure-activity profile of substituted purines and inflammation in the delayed hypersensitivity skin reaction.

Authors:  R J Wojnar; K A Losee; R J Brittain
Journal:  Agents Actions       Date:  1975-05

8.  Enhancement of antibody synthesis by 6-mercaptopurine.

Authors:  D Chanmougan; R S Schwartz
Journal:  J Exp Med       Date:  1966-09-01       Impact factor: 14.307
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.